We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




In Vivo Imaging Technology Integrates Fluorescence, Bioluminescence, and X-Ray Modalities

By MedImaging International staff writers
Posted on 25 Sep 2009
Print article
New technology combines highly sensitive bioluminescence and fluorescence molecular optical imaging with the anatomic accuracy of digital X-ray. Integrating these three imaging modalities provides researchers with additional capabilities to explore the molecular basis of disease and determine the response to drug therapies.

Caliper Life Sciences, Inc. (Hopkinton, MA, USA), a provider of tools and services for drug discovery and life sciences research, introduced the IVIS Lumina XR in vivo imaging system, the latest addition to the IVIS product range. Caliper's noninvasive IVIS preclinical molecular optical imaging technology is an innovative research tool that has greatly advanced both basic scientific research as well as the novel breakthrough research necessary to develop safe new drugs.

To date, peer-reviewed publications show that IVIS technology has aided the discovery and development of five U.S. Food and Drug Administration (FDA)-approved therapies and more than nine drug compounds in development. The introduction of the Lumina XR system takes this innovation one step further by combining optical fluorescent and bioluminescent images of biologic activity with coregistered digital X-ray images, enhancing the anatomical context of the optical molecular signals. For example, with X-ray coregistration the researcher can view a detailed image of the skeleton, or even certain soft tissues, and can use those images as a reference point when using bioluminescence to more precisely locate a tumor or infection site in an animal.

"Caliper's bioluminescent and fluorescent IVIS imaging systems are well-recognized by researchers at top universities and pharmaceutical companies as the leading preclinical in vivo imaging solution," said Kevin Hrusovsky, president and chief executive officer, Caliper Life Sciences. "The demand for advanced preclinical imaging technologies continues to increase, and Caliper is meeting that demand by offering a multimodality solution that will enhance current research applications and further enable newer areas of research, including bone disease and arthritis. We remain committed to providing scientists with valuable tools that translate experimentation into viable clinical options."

All IVIS systems are optically capable of imaging the full spectrum of fluorescent and bioluminescent reporters and dyes, from green to near infrared, with quantitative results and high performance spectral unmixing, to extract maximum information from animal models. Lumina XR can incorporate the premium animal-handling features of Caliper's other IVIS imaging systems, such as a heated stage, gas anesthesia connections, and a syringe injection system for simultaneous compound administration. In addition to mice, the Lumina XR can accommodate Petri dishes or microtiter plates for in vitro imaging. Similar to Caliper's other IVIS imaging systems, the Lumina XR will serve a wide array of therapeutic areas, including cancer research, infectious disease, inflammation, metabolic disease, neurology, cardiovascular disease, toxicology, and other applications.

Caliper Life Sciences is a provider of technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper's range of products includes microfluidics, lab automation and liquid handling, optical imaging technologies, and discovery and development outsourcing solutions.

Related Links:
Caliper Life Sciences


Silver Member
X-Ray QA Meter
T3 AD Pro
Multi-Use Ultrasound Table
Clinton
New
MRI Infusion Workstation
BeneFusion MRI Station
Ultrasound Table
Women’s Ultrasound EA Table

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.